HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
|
Citation:
|
HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
|
HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
|
Citation:
|
HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
|
DownLoad: